Senol Kobak
10.2174/1574886314666190528121039
Curr Drug Saf
2019;14(3):225-229.
immune checkpoint inhibitor arthritis fasciitis lung adenocarcinoma pembrolizumab rheumatic feature
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/31132977/
Adenocarcinoma of Lung / drug therapy Antibodies, Monoclonal, Humanized / adverse effects Arthritis / chemically induced Lung Neoplasms / drug therapy
Adenocarcinoma of Lung / drug therapy Antibodies, Monoclonal, Humanized / adverse effects Arthritis / chemically induced Lung Neoplasms / drug therapy Case Reports Aged Antibodies, Monoclonal, Humanized / therapeutic use Arthritis / diagnostic imaging Humans Male Antibodies, Monoclonal, Humanized pembrolizumab
PMC6864613
31132977
Pembrolizumab-Induced Seronegative Arthritis and Fasciitis in a Patient with Lung Adenocarcinoma
2019